Erik J. Peterson, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 101 N. Harrison, Lindsborg, KS 67456 Phone: 785-227-2299 Fax: 785-227-2620 |
News Archive
Labopharm Inc. today announced the closing of its previously announced underwritten public offering of 11,764,706 units. The units were sold at a price of US$1.70 per unit for gross proceeds of US$20 million. Net proceeds were US$18,150,000 after deducting underwriting discounts and commissions, and estimated offering expenses.
The National Federation of Independent Business asked the Supreme Court to add two additional plaintiffs to its health law challenge after the initial plaintiff in the case filed for bankruptcy.
S*BIO Pte Ltd today announced that a fourth novel, potential best-in-class compound discovered and developed by S*BIO has entered a Phase 1 clinical trial. The initiation of the study for S*BIO's oral multi-kinase inhibitor, SB1317 or TG02, in patients with advanced/refractory hematologic malignancies has triggered a payment from S*BIO's development and commercialization partner for the program, Tragara Pharmaceuticals.
Biophysicists have developed a hypothesis to explain the function of a light-driven protein which pumps sodium ions across a cell membrane, and they have revealed the key structural feature of these pumps. The scientists see these sodium pumps as being highly promising tools in using light signals to control nerve cells – which is exactly what is involved in the new scientific field of optogenetics.
› Verified 9 days ago